Pure Global
NCT02588898

B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes

Universität des Saarlandes·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Complications
Drug/Device/Intervention
Blood collection and electrophysiological tests
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Universität des Saarlandes
Location
Homburg, Germany
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2009
End date
Jan 01, 2011
Enrollment
212 participants
Primary outcome

Red blood cell cobalamin levels,Polyneuropathy grade estimated using a score including a combination of data from questionnaire and electrophysiology investigations

Summary

This case-control study investigated B-vitamin and homocysteine in relation to the presence
 or the absence of type 2 diabetes and clinical signs of polyneuropathy.

ICD-10 classifications
Unspecified diabetes mellitus without complicationsOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus without complicationsUnspecified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT02588898
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT02588898 through Pure Global AI's free database. This phase not specified trial is sponsored by Universität des Saarlandes and is currently Completed. The study focuses on Diabetes Complications. Target enrollment is 212 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.